Atenolol vs lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Comparative Analysis of Atenolol vs. Lisinopril in Hypertension Management
Introduction to Atenolol and Lisinopril
Atenolol and lisinopril are commonly prescribed medications for managing hypertension. Atenolol is a beta-blocker, while lisinopril is an angiotensin-converting enzyme (ACE) inhibitor. Both drugs have distinct mechanisms of action and are used to treat various cardiovascular conditions, including hypertension and heart failure.
Blood Pressure Control in Essential Hypertension
Efficacy in Blood Pressure Reduction
Several studies have compared the efficacy of atenolol and lisinopril in reducing blood pressure in patients with mild to moderate essential hypertension. Lisinopril has been shown to produce a greater reduction in systolic blood pressure compared to atenolol 469. Both medications effectively reduce diastolic blood pressure to a similar extent 69. This suggests that while both drugs are effective, lisinopril may offer superior control of systolic blood pressure.
Safety and Tolerability
Both atenolol and lisinopril are generally well-tolerated. However, adverse effects can differ between the two. Lisinopril is associated with a higher incidence of cough, while atenolol may lead to elevated triglycerides 10. Additionally, sexual dysfunction has been reported more frequently with atenolol compared to lisinopril 7.
Cardiovascular Outcomes in Hemodialysis Patients
Left Ventricular Hypertrophy and Cardiovascular Events
In patients undergoing hemodialysis, atenolol-based therapy has been found to be superior to lisinopril-based therapy in preventing cardiovascular morbidity and all-cause hospitalizations 1. Although both drugs improved left ventricular mass index (LVMI) over time, atenolol was associated with fewer serious cardiovascular events and hospitalizations for heart failure 1.
Arterial Stiffness
Atenolol has also been shown to reduce aortic pulse wave velocity more effectively than lisinopril in hemodialysis patients, indicating better improvement in arterial stiffness 5. This effect is primarily attributed to the blood pressure-lowering properties of atenolol.
Kidney Function in Diabetic Nephropathy
Glomerular Filtration Rate and Albuminuria
In hypertensive patients with non-insulin-dependent diabetes mellitus (NIDDM) and diabetic nephropathy, both atenolol and lisinopril effectively slow the decline in kidney function 23. However, lisinopril has a more pronounced effect on reducing urinary albumin excretion, which is a marker of kidney damage 23. This suggests that lisinopril may offer additional renoprotective benefits beyond blood pressure control.
Hemodynamics and Left Ventricular Function
Experimental Mitral Regurgitation
In experimental models of chronic mitral regurgitation, lisinopril significantly reduced preload but had an insignificant effect on left ventricular contractility. Conversely, the addition of atenolol to lisinopril therapy restored left ventricular contractility to normal levels, providing maximum hemodynamic benefit 8.
Conclusion
Both atenolol and lisinopril are effective antihypertensive agents with distinct advantages and limitations. Lisinopril may offer superior systolic blood pressure control and renoprotective effects, while atenolol is more effective in reducing arterial stiffness and preventing cardiovascular events in hemodialysis patients. The choice between these medications should be tailored to the individual patient's clinical profile and specific health needs.
Sources and full results
Most relevant research papers on this topic